Global barbiturate drug market is anticipated to grow at a moderate CAGR of 3.5% during the forecast period (2024-2031). The rising prevalence of insomnia along with growing awareness regarding availability of drugs such as barbiturate drug for its easy treatment is a key factor driving the global barbiturate drug market. A study published in April 2020 by the American Journal of Managed Care, states that insomnia is one of the most prevalent sleep disorders and a significant financial burden on the healthcare system in the US. Over $100.0 billion is spent on insomnia-related expenses in the US each year, both direct and indirect. The use of barbiturate medications to treat common sleep problems in the elderly is becoming more and more popular globally. The demand for pharmacological remedies has increased as seniors become more conscious of the negative effects untreated sleep disturbances can have on their health.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/barbiturate-drug-market
The ongoing trend for personalized medicine especially in the treatment of sleep disorders is further aiding to the market growth. Recent developments in genetic testing allow the identification of particular markers associated with response to barbiturate drugs or sleep disorders, allowing for more focused therapies. The ability to precisely diagnose patients enables medical practitioners to tailor treatment regimens and maximize the usage of barbiturate medications based on patient requirements.
To gain on market share, in April 2021, Ethypharm established its direct presence in Italy. It is the third largest pharmaceutical market in Europe. Under the leadership of Bruno Rago, Ethypharm Italy has reinforced the group’s commercial footprint in Europe, notably in its core therapeutic area of the Central Nervous System.
Global Barbiturate Drug Market Report Segment
By Type
- Long-acting Barbiturate
- Short-acting Barbiturate
- Ultra-short Acting Barbiturate
- Combination Drugs
By Application
- Insomnia
- Epilepsy
- Sedation
- Other
A full report of Barbiturate Drug Market available @ https://www.omrglobal.com/industry-reports/barbiturate-drug-market
Barbiturate Drug Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie Inc.
- Centurion Healthcare Private Ltd.
- Ethypharm
- GSK Plc.
- Intas Pharmaceuticals Ltd.
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
